CBB: BGI Joins with Clearbridge BioMedics to Develop Liquid Biopsy in China

BGI the Shenzhen "omics" company has partnered with Singapore's Clearbridge BioMedics to distribute and develop its liquid biopsy product in greater China. CBB's ClearCell® FX1 product separates circulating tumor cells CTC from the blood....